After years of consumers tracking health metrics without clear guidance on how to use them, NeuroRester Corp. has unveiled its vision for the next generation of wearable wellness technology. The company today announced the launch of Wearable 2.0, anchored by its flagship devices, NeuroRester and CardioGyms. At the center of this ecosystem is the proprietary NAP (Nightly-Active Protocol), a system developed to transform wearable technology from a passive data-collection tool into an active wellness support platform.

The rise of the "Quantified Self" movement introduced consumers to smartwatches, rings, and other devices capable of measuring metrics such as Heart Rate Variability (HRV), sleep quality, and recovery scores. While these devices provide valuable insights, they often leave users wondering how to translate data into meaningful action. Wearable 2.0 seeks to address this challenge by offering personalized guidance based on the information users already collect.

Moving Beyond Observation
According to NeuroRester Corp., traditional wearable technology has largely focused on monitoring and reporting health information without offering direct support for wellness improvement. Wearable 2.0 introduces a different approach by integrating intelligent data processing and personalized recommendations.
 

NAP: Personalized Wellness Support
Serving as the foundation of the ecosystem, NAP (Nightly-Active Protocol) connects existing wearable devices—including Apple Watch, Oura, and WH—with NeuroRester's hardware solutions. Once users define their wellness goals and preferences within the app, the protocol automatically schedules customized wellness sessions designed to encourage consistent relaxation and recovery habits that fit naturally into daily life.

The Device Ecosystem
NeuroRester
A compact earbud-style device that incorporates Bioboosti technology to help users relax and support a greater sense of calm.

CardioGyms
A flexible wearable that can be worn on the wrist, calf, or integrated into specialized socks, offering comfort throughout the day while supporting relaxation-focused wellness routines.
"People are no longer satisfied with simply receiving reports that indicate poor sleep or low recovery," said NeuroRester Corp.'s Founder and CEO. "They want practical ways to improve how they feel. Wearable 2.0 and NAP help convert health data into simple, personalized wellness actions, shifting the conversation from understanding the numbers to taking meaningful steps based on them."

Availability
Early Access enrollment will begin in mid-June and will be limited to the first 1,000 participants, who will receive special introductory pricing. Broader product availability is planned for July 2026 through NeuroRester's official website.

About NeuroRester Corp.
Headquartered in Campbell, California, NeuroRester Corp. is advancing the Wearable 2.0 category through the development of proprietary wellness technologies. Its innovations, including NAP and Bioboosti, are designed to support natural relaxation, recovery, and overall well-being.

Important Information
Statements regarding these products have not been reviewed by the U.S. Food and Drug Administration. NeuroRester and CardioGyms are intended for wellness purposes only and are not designed to diagnose, treat, cure, or prevent any disease or medical condition. Descriptions of expected wellness benefits are based on product design objectives and user experience goals; outcomes have not been clinically validated and may differ among individuals.

To deliver personalized wellness experiences, NeuroRester Corp. utilizes health information collected from compatible wearable devices.

CES 2026 took place in Las Vegas from January 6–9, bringing together 4,112 prominent companies from across the globe. Among them, Yuwell Medical marked its first-ever appearance at the event, representing China’s medical device industry on the international stage.

During the exhibition, Yuwell Medical presented a broad range of solutions spanning respiratory care, chronic condition management, emergency care, and smart wearable technology. Its respiratory lineup—including the Pocket S portable breathcare device and the SP-6 Pro portable oxygen concentrator—highlighted the growing importance of mobility in medical applications. For chronic disease monitoring, products such as the YE699 fully automatic electronic blood pressure monitor demonstrated Yuwell’s focus on delivering more accurate and intelligent health management tools.

One of the standout attractions at the booth was the debut of the Yuwell R3 Health Ring. Designed with a titanium alloy body and medical-grade resin, the ring combines an ultra-light structure with a skin-friendly finish, ensuring comfort throughout the day. It supports continuous, multi-parameter health tracking, monitoring sleep patterns, heart rate, blood oxygen saturation, and daily activity. Enhanced by AI-based health analysis and abnormal condition alerts, the R3 Health Ring also offers up to seven days of battery life during standard use.

Leveraging more than two decades of expertise in medical-grade monitoring technologies—including blood oxygen, heart rate, and sleep tracking—Yuwell has collaborated with professional medical institutions to integrate advanced sensors with its proprietary AI algorithms. This collaboration aims to solve a persistent challenge in the wearable sector: delivering high data accuracy without compromising comfort or meaningful health insights.

Yuwell Medical’s presence at CES underscored its long-term vision for AI-powered healthcare devices. Artificial intelligence is reshaping medical monitoring from basic data collection tools into proactive health companions. This shift is driven by four major trends: elevating devices from reference-level data providers to sources of clinically reliable insights; making health monitoring more unobtrusive through thinner, lighter wearable designs; transitioning from historical data review to predictive risk alerts using AI models; and creating an interconnected ecosystem where devices work together to support individual and family health management.

Commenting on the company’s direction, Hua Hao, General Manager of Yuwell’s AI Wearable Medical Business, said: “Our innovation strategy is closely tied to globalization, digital transformation, and wearable technology. By uniting hardware, algorithms, and services, we are bringing professional-grade monitoring—traditionally confined to hospitals—into everyday life, supporting a prevention-oriented, closed-loop approach to health management.”